Philip S Low

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 31

Top Venues

Bioconjugate chemistry

Molecular pharmaceutics

PloS one

Biomedicines

Purdue University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Purdue University

United States

Director Center for Drug Discovery, Distinguished Professor of Chemistry :: Chemistry

Publications

Jeffery J Nielsen, Stewart A Low, Christopher Chen, Xinlan Li, Ephraim Mbachu, Lina Trigg, Siyuan Sun, Madeline Tremby, Rahul Hadap, Philip S Low
Targeted Delivery of Abaloparatide to Spinal Fusion Site Accelerates Fusion Process in Rats. Biomedicines 12 (3) (2024)
Jeffery J Nielsen, Stewart A Low, Christopher Chen, Xinlan Li, Ephraim Mbachu, Lina Trigg, Siyuan Sun, Madeline Tremby, Rahul Hadap, Philip S Low
Targeted Delivery of Abaloparatide to Spinal Fusion Site Accelerates Fusion Process in Rats. Biomedicines 12 (3) (2024)
Gregory Thomas Kennedy, Feredun S Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley E Chang, Alix Segil, Sean Carlin, Neil T Sullivan, Emmanuel Encarnado, Charuhas Desphande, Sumith Kularatne, Pravin Gagare, Mini Thomas, John C Kucharczuk, Gaetan Christien, Francois Lacombe, Kaela Leonard, Philip S Low, Aline Criton, Sunil Singhal
Targeted detection of cancer at the cellular level during biopsy by near-infrared confocal laser endomicroscopy. Nature communications 13 (1) (2022)
Qian Luo, John V Napoleon, Xin Liu, Boning Zhang, Suilan Zheng, Philip S Low
Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors. Molecular cancer research : MCR 20 (5) (2022)
John Victor Napoleon, Boning Zhang, Qian Luo, Madduri Srinivasarao, Philip S Low
Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells. Angewandte Chemie (International ed. in English) 61 (15) (2022)
Gregory Thomas Kennedy, Feredun S Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley E Chang, Alix Segil, Neil Sullivan, Isvita Marfatia, Azra Din, Charuhas Desphande, John C Kucharczuk, Philip S Low, Sunil Singhal
A Prostate-Specific Membrane Antigen-Targeted Near-Infrared Conjugate for Identifying Pulmonary Squamous Cell Carcinoma during Resection. Molecular cancer therapeutics 21 (4) (2022)
Huynh Dinh Chien, Antonella Pantaleo, Kristina R Kesely, Panae Noomuna, Karson S Putt, Tran Anh Tuan, Philip S Low, Francesco M Turrini
Imatinib augments standard malaria combination therapy without added toxicity. The Journal of experimental medicine 218 (10) (2021)
Xin Liu, Weichuan Luo, Boning Zhang, Yong Gu Lee, Imrul Shahriar, Madduri Srinivasarao, Philip S Low
Design of Neuraminidase-Targeted Imaging and Therapeutic Agents for the Diagnosis and Treatment of Influenza Virus Infections. Bioconjugate chemistry 32 (8) (2021)
Sakkarapalayam M Mahalingam, Karson S Putt, Madduri Srinivasarao, Philip S Low
Design of a Near Infrared Fluorescent Ureter Imaging Agent for Prevention of Ureter Damage during Abdominal Surgeries. Molecules (Basel, Switzerland) 26 (12) (2021)
Suraj U Hettiarachchi, Yen-Hsing Li, Jyoti Roy, Fenghua Zhang, Estela Puchulu-Campanella, Spencer D Lindeman, Madduri Srinivasarao, Konstantin Tsoyi, Xiaoliang Liang, Ehab A Ayaub, Cheryl Nickerson-Nutter, Ivan O Rosas, Philip S Low
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models. Science translational medicine 12 (567) (2021)
Ioannis Tsamesidis, Karine Reybier, Giuseppe Marchetti, Maria Carmina Pau, Patrizia Virdis, Claudio Fozza, Francoise Nepveu, Philip S Low, Francesco Michelangelo Turrini, Antonella Pantaleo
Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in Plasmodium falciparum-Parasitized Erythrocytes. Antioxidants (Basel, Switzerland) 9 (8) (2020)
Xin Liu, Boning Zhang, Yingcai Wang, Hanan S Haymour, Fenghua Zhang, Le-Cun Xu, Madduri Srinivasarao, Philip S Low
A universal dual mechanism immunotherapy for the treatment of influenza virus infections. Nature communications 11 (1) (2020)
Fenghua Zhang, Ehab A Ayaub, Bingbing Wang, Estela Puchulu-Campanella, Yen-Hsing Li, Suraj U Hettiarachchi, Spencer D Lindeman, Qian Luo, Sasmita Rout, Madduri Srinivasarao, Abigail Cox, Konstantin Tsoyi, Cheryl Nickerson-Nutter, Ivan O Rosas, Philip S Low
Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosis. EMBO molecular medicine 12 (8) (2020)
Maria Carmina Pau, Antonella Pantaleo, Ioannis Tsamesidis, Ha Hoang, Anh Tuan Tran, Thi Lien Hanh Nguyen, Thi Hang Giang Phan, Phuong Anh Ton Nu, Thi Minh Chau Ngo, Giuseppe Marchetti, Evelin Schwarzer, Pier Luigi Fiori, Philip S Low, Chien Dinh Huynh, Francesco Michelangelo Turrini
Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam. PloS one 14 (4) (2019)
Hanwen Zhang, Ananda Kumar Kanduluru, Pooja Desai, Afruja Ahad, Sean Carlin, Nidhi Tandon, Wolfgang A Weber, Philip S Low
Synthesis and Evaluation of a Novel 64Cu- and 67Ga-Labeled Neurokinin 1 Receptor Antagonist for in Vivo Targeting of NK1R-Positive Tumor Xenografts. Bioconjugate chemistry 29 (4) (2018)
Sakkarapalayam M Mahalingam, Sumith A Kularatne, Carrie H Myers, Pravin Gagare, Mohammad Norshi, Xin Liu, Sunil Singhal, Philip S Low
Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer. Journal of medicinal chemistry 61 (21) (2018)
Isaac S Marks, Spencer S Gardeen, Sarah J Kurdziel, Sonia T Nicolaou, J Evan Woods, Sumith A Kularatne, Philip S Low
Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers. Molecular pharmaceutics 15 (6) (2018)
Mohamed S A Elsayed, Jeffery J Nielsen, Sungtae Park, Jeongho Park, Qingyang Liu, Chang H Kim, Yves Pommier, Keli Agama, Philip S Low, Mark Cushman
Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series. Journal of medicinal chemistry 61 (23) (2018)
Sakkarapalayam M Mahalingam, Haiyan Chu, Xin Liu, Christopher P Leamon, Philip S Low
Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic Tumors. Bioconjugate chemistry 29 (10) (2018)
Mingding Wang, Soie Park, Yoonhee Nam, Jeffery Nielsen, Stewart A Low, Madduri Srinivasarao, Philip S Low
Bone-Fracture-Targeted Dasatinib-Oligoaspartic Acid Conjugate Potently Accelerates Fracture Repair. Bioconjugate chemistry 29 (11) (2018)
Loganathan Rangasamy, Venkatesh Chelvam, Ananda Kumar Kanduluru, Madduri Srinivasarao, N Achini Bandara, Fei You, Esteban A Orellana, Andrea L Kasinski, Philip S Low
New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange. Bioconjugate chemistry 29 (4) (2018)
Jyoti Roy, Miranda Kaake, Madduri Srinivasarao, Philip S Low
Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers. Bioconjugate chemistry 29 (7) (2018)
Sakkarapalayam M Mahalingam, Fernando Dip, Marco Castillo, Mayank Roy, Steven D Wexner, Raul J Rosenthal, Philip S Low
Intraoperative Ureter Visualization Using a Novel Near-Infrared Fluorescent Dye. Molecular pharmaceutics 15 (8) (2018)
Scott Poh, Karson S Putt, Philip S Low
Folate-Targeted Dendrimers Selectively Accumulate at Sites of Inflammation in Mouse Models of Ulcerative Colitis and Atherosclerosis. Biomacromolecules 18 (10) (2017)
Qingshou Chen, Xiangjun Meng, Paul McQuade, Daniel Rubins, Shu-An Lin, Zhizhen Zeng, Hyking Haley, Patricia Miller, Dinko González Trotter, Philip S Low
Folate-PEG-NOTA-Al18F: A New Folate Based Radiotracer for PET Imaging of Folate Receptor-Positive Tumors. Molecular pharmaceutics 14 (12) (2017)
Ananda Kumar Kanduluru, Philip S Low
Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers. Molecular pharmaceutics 14 (11) (2017)
Rachel L Merzel, Carolina Frey, Junjie Chen, Rachel Garn, Mallory van Dongen, Casey A Dougherty, Ananda Kumar Kandaluru, Philip S Low, E Neil G Marsh, Mark M Banaszak Holl
Conjugation Dependent Interaction of Folic Acid with Folate Binding Protein. Bioconjugate chemistry 28 (9) (2017)
Madduri Srinivasarao, Philip S Low
Ligand-Targeted Drug Delivery. Chemical reviews 117 (19) (2017)
Sakkarapalayam M Mahalingam, Vadim Y Dudkin, Shalom Goldberg, Donna Klein, Fang Yi, Sunil Singhal, Karyn T O'Neil, Philip S Low
Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors. Bioconjugate chemistry 28 (11) (2017)
Jeff Spector, Gayani C Kodippili, Ken Ritchie, Philip S Low
Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes. PloS one 11 (9) (2016)
Kristina R Kesely, Antonella Pantaleo, Francesco M Turrini, Peter Olupot-Olupot, Philip S Low
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia. PloS one 11 (10) (2016)

Philip S Low.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Philip S Low